Aquatic Capital Management LLC Kala Pharmaceuticals, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $11.7 $2,325 - $108,810	-9,300 Reduced 70.45%	3,900 $1,000
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.31 $3,600 - $15,720	12,000 Added 1000.0%	13,200 $4,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $3,050 - $9,200	-5,000 Reduced 80.65%	1,200 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $7,191 - $16,988	6,200 New	6,200 $8,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.1M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.